Patients with advanced Merkel cell carcinoma had significant increases in survival rates following FDA approval of immune checkpoint inhibitors.

The DecisionDx-Melanoma test accurately identifies low sentinel lymph node risk in melanoma, according to the DECIDE study.

Immune checkpoint (IC) inhibitor drug holidays are safe in patients with metastatic melanoma who achieve an objective response (OR) during therapy, according to a study of more than 200 patients in ...

Unfortunately, routine cancer screening rates have declined significantly in the United States, a new survey says. Only 51% of adults 21 and older say they've had a routine medical appointment or ...

One key benefit of enrolling in a clinical trial is the high level of care and attention patients receive. Patients are ...

The chances of surviving cancer are greatly improved when it’s discovered early, yet a new study shows a decrease in the ...

The five-year survival rate for patients with distant metastatic melanoma remains low, at approximately 35%. BioNTech and Regeneron are competing with rivals Moderna and MSD in the mRNA melanoma ...

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

The author says older tennis players can be safe and competitive. Good preparation, smart play and a healthy attitude are keys to success.

USA News Group News Commentary – Routine medical appointments or cancer screening rates—an important aspect in increasing survival rates—have sunk to just over ...